Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 232

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 1A
Chunk 232
---
585,239 shares of common stock. As a result, as of March 31, 2025 we had 57,023,811 shares of
common stock available for issuance to new investors or for use to satisfy indebtedness or pay service providers.

 44 

On
March 16, 2025, Aethlon Medical, Inc. (the “Company”) entered into
an inducement offer to exercise existing Class A and Class B Warrants (the “Agreement”) with a certain accredited and institutional
holder (the “Holder”) of the Company’s outstanding Class A and Class B Warrants issued on May 17, 2024 (the “Existing
Warrants”). Pursuant to the Agreement, the Holder, upon exercise, will receive a new unregistered Common Stock Purchase Warrant
(“New Warrant”) pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (“Securities Act”), to purchase
up to a number of shares equal to 200% of the number of Warrant Shares issued pursuant to the exercise of Existing Warrants pursuant to
this Agreement (the “New Warrant Shares”), which New Warrant shall have an exercise price per share equal to $0.3736, subject
to adjustment as provided in the New Warrant, will be exercisable at any time on or after six (6) months from the date of issuance and
have a term of exercise of five and one-half (5.5) years from the date of issuance and a reduction of the exercise price of the Existing
Warrants to $0.3736 per share, representing the closing price on March 14, 2025, but only with respect to a cash exercise under the
Existing Warrants (as reduced from the current respective exercise price per share as set forth in the Existing Warrants).

The
closing took place on March 17, 2025. Gross proceeds to the Company from the exercise of the Existing Warrants was $2,316,320, prior to
deducting closing costs and placement agent fees as further described below. The Company intends to use the net proceeds from the offering
for working capital and general corporate purposes.

As
a result of the Holder exercising the Existing Warrants, the Company issued an aggregate of 6,200,000 shares of its common stock. The
shares underlying the Existing Warrants have all been registered on Form S-1 registration statement (Registration